PriceTargets.com logo

Tenet Healthcare - THC Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $230.88
  • Forecasted Upside: 8.89%
  • Number of Analysts: 21
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 16 Buy Ratings
  • 1 Strong Buy Ratings
$212.02 As of 12/4/2025 04:59 PM ET
▲ +0.68 (0.32%)

This chart shows the closing price for THC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Tenet Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for THC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for THC

Analyst Price Target is $230.88
▲ +8.89% Upside Potential
This price target is based on 21 analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $230.88, with a high forecast of $260.00 and a low forecast of $167.00. The average price target represents a 8.89% upside from the last price of $212.02.

This chart shows the closing price for THC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 21 polled investment analysts is to moderate buy stock in Tenet Healthcare. This rating has held steady since December 2024, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 2 strong buy ratings
  • 15 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 2 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 2 strong buy ratings
  • 13 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 1 strong buy ratings
  • 14 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 1 strong buy ratings
  • 15 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 1 strong buy ratings
  • 14 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 1 strong buy ratings
  • 15 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 1 strong buy ratings
  • 16 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 1 strong buy ratings
  • 16 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/2/2025GuggenheimBoost TargetBuy ➝ Buy$238.00 ➝ $257.00
12/1/2025Weiss RatingsReiterated RatingBuy (B-) ➝ Buy (B-)
11/24/2025Weiss RatingsReiterated RatingBuy (B-) ➝ Buy (B-)
11/21/2025BarclaysBoost TargetOverweight ➝ Overweight$229.00 ➝ $240.00
11/17/2025Weiss RatingsReiterated RatingBuy (B-) ➝ Buy (B-)
11/13/2025JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$200.00 ➝ $230.00
11/13/2025Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$238.00 ➝ $252.00
11/11/2025Weiss RatingsUpgradeHold (C+) ➝ Buy (B-)
11/3/2025Truist FinancialReiterated RatingBuy ➝ Buy$225.00 ➝ $240.00
10/30/2025Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$230.00 ➝ $252.00
10/29/2025Raymond James FinancialSet Target$245.00
10/29/2025UBS GroupBoost TargetBuy ➝ Buy$238.00 ➝ $260.00
10/29/2025Morgan StanleySet TargetOverweight ➝ Overweight$232.00
10/29/2025GuggenheimBoost TargetBuy ➝ Buy$221.00 ➝ $238.00
10/29/2025Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$190.00 ➝ $245.00
10/17/2025MizuhoBoost TargetOutperform ➝ Outperform$194.00 ➝ $225.00
10/14/2025Truist FinancialSet Target$225.00
10/14/2025The Goldman Sachs GroupInitiated CoverageBuy$224.00
10/14/2025The Goldman Sachs GroupInitiated CoverageBuy$224.00
10/8/2025KeyCorpBoost TargetOverweight ➝ Overweight$205.00 ➝ $225.00
10/8/2025Weiss RatingsReiterated RatingHold (C+) ➝ Hold (C+)
10/7/2025Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$200.00 ➝ $238.00
10/7/2025Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$190.00
10/6/2025Zacks ResearchDowngradeStrong-Buy ➝ Hold
9/27/2025Weiss RatingsReiterated RatingHold (C+) ➝ Hold (C+)
9/18/2025BarclaysBoost TargetOverweight ➝ Overweight$208.00 ➝ $229.00
9/10/2025Bank of AmericaBoost TargetBuy ➝ Buy$205.00 ➝ $225.00
8/26/2025Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$190.00
8/14/2025Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$195.00 ➝ $200.00
8/4/2025JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$190.00 ➝ $200.00
7/28/2025Wolfe ResearchDowngradeOutperform ➝ Peer Perform
7/25/2025Robert W. BairdLower TargetNeutral ➝ Neutral$195.00 ➝ $167.00
7/24/2025BarclaysLower TargetOverweight ➝ Overweight$215.00 ➝ $208.00
7/23/2025UBS GroupBoost TargetBuy ➝ Buy$230.00 ➝ $238.00
7/23/2025Raymond James FinancialReiterated RatingOutperform ➝ Outperform$185.00 ➝ $200.00
7/23/2025GuggenheimBoost TargetBuy ➝ Buy$180.00 ➝ $188.00
7/16/2025Truist FinancialBoost TargetBuy ➝ Buy$190.00 ➝ $205.00
7/11/2025MizuhoBoost TargetOutperform ➝ Outperform$184.00 ➝ $194.00
6/9/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$175.00 ➝ $210.00
6/2/2025StephensUpgradeStrong-Buy
6/2/2025BarclaysBoost TargetOverweight ➝ Overweight$171.00 ➝ $215.00
5/29/2025Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$150.00 ➝ $195.00
5/14/2025Bank of AmericaBoost TargetBuy ➝ Buy$165.00 ➝ $180.00
5/12/2025Truist FinancialBoost TargetBuy ➝ Buy$175.00 ➝ $190.00
5/5/2025The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$134.00 ➝ $154.00
5/5/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$165.00 ➝ $175.00
4/30/2025BarclaysBoost TargetOverweight ➝ Overweight$161.00 ➝ $171.00
4/30/2025Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$183.00 ➝ $189.00
4/30/2025UBS GroupBoost TargetBuy ➝ Buy$217.00 ➝ $230.00
4/15/2025Baird R WDowngradeStrong-Buy ➝ Hold
4/15/2025Robert W. BairdReiterated RatingOutperform ➝ Neutral$153.00 ➝ $137.00
4/9/2025GuggenheimInitiated CoverageBuy$165.00
3/26/2025Morgan StanleyInitiated CoverageOverweight$165.00
2/26/2025TD CowenInitiated CoverageBuy$175.00
2/13/2025Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$177.00 ➝ $177.00
2/13/2025BarclaysLower TargetOverweight ➝ Overweight$190.00 ➝ $161.00
1/7/2025KeyCorpLower TargetOverweight ➝ Overweight$200.00 ➝ $185.00
1/6/2025Truist FinancialLower TargetBuy ➝ Buy$190.00 ➝ $175.00
12/17/2024JPMorgan Chase & Co.Reiterated RatingOverweight$175.00
12/16/2024The Goldman Sachs GroupDowngradeBuy ➝ Neutral$196.00 ➝ $140.00
11/25/2024Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$205.00 ➝ $150.00
11/22/2024Raymond James FinancialDowngradeStrong-Buy ➝ Outperform$195.00 ➝ $195.00
11/8/2024BarclaysBoost TargetOverweight ➝ Overweight$171.00 ➝ $190.00
11/6/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$195.00 ➝ $205.00
10/30/2024The Goldman Sachs GroupBoost TargetBuy ➝ Buy$173.00 ➝ $196.00
10/30/2024Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$168.00 ➝ $177.00
10/30/2024Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$174.00 ➝ $183.00
10/30/2024Truist FinancialReiterated RatingBuy ➝ Buy$180.00 ➝ $190.00
10/30/2024UBS GroupBoost TargetBuy ➝ Buy$197.00 ➝ $217.00
10/22/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$175.00 ➝ $195.00
10/14/2024Truist FinancialBoost TargetBuy ➝ Buy$170.00 ➝ $180.00
10/11/2024KeyCorpInitiated CoverageOverweight$200.00
10/10/2024KeyCorpUpgradeStrong-Buy
10/1/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$168.00 ➝ $168.00
8/19/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$168.00 ➝ $168.00
8/14/2024UBS GroupBoost TargetBuy ➝ Buy$180.00 ➝ $197.00
7/30/2024The Goldman Sachs GroupBoost TargetBuy ➝ Buy$156.00 ➝ $173.00
7/30/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$145.00 ➝ $175.00
7/29/2024BarclaysBoost TargetOverweight ➝ Overweight$156.00 ➝ $171.00
7/25/2024Raymond James FinancialBoost TargetStrong-Buy ➝ Strong-Buy$130.00 ➝ $175.00
7/25/2024CitigroupBoost TargetBuy ➝ Buy$139.00 ➝ $171.00
7/25/2024Truist FinancialReiterated RatingBuy ➝ Buy$155.00 ➝ $170.00
7/25/2024Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$112.00 ➝ $168.00
7/15/2024Truist FinancialBoost TargetBuy ➝ Buy$130.00 ➝ $155.00
7/10/2024BarclaysBoost TargetOverweight ➝ Overweight$147.00 ➝ $156.00
7/9/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$112.00 ➝ $112.00
7/2/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$112.00 ➝ $112.00
6/28/2024Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$150.00 ➝ $155.00
5/30/2024Baird R WUpgradeStrong-Buy
5/30/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$107.00 ➝ $140.00
5/30/2024Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$126.00 ➝ $150.00
5/30/2024Robert W. BairdInitiated CoverageOutperform$153.00
5/2/2024BarclaysBoost TargetOverweight ➝ Overweight$113.00 ➝ $147.00
5/1/2024Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$109.00 ➝ $136.00
5/1/2024UBS GroupBoost TargetBuy ➝ Buy$137.00 ➝ $150.00
5/1/2024MizuhoReiterated RatingBuy ➝ Buy$118.00 ➝ $130.00
5/1/2024Truist FinancialReiterated RatingBuy ➝ Buy$120.00 ➝ $130.00
5/1/2024StephensBoost TargetEqual Weight ➝ Equal Weight$95.00 ➝ $122.00
4/12/2024Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$100.00 ➝ $126.00
4/10/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$104.00
3/28/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$105.00 ➝ $115.00
3/27/2024Wolfe ResearchUpgradePeer Perform ➝ Outperform$122.00
3/6/2024BarclaysInitiated CoverageOverweight$113.00
3/5/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$104.00
2/15/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$98.00 ➝ $105.00
2/9/2024Truist FinancialBoost TargetBuy ➝ Buy$92.00 ➝ $105.00
2/9/2024Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$97.00 ➝ $109.00
2/9/2024MizuhoBoost TargetBuy ➝ Buy$90.00 ➝ $100.00
2/9/2024Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$94.00 ➝ $104.00
11/20/2023Truist FinancialReiterated RatingBuy ➝ Buy$92.00
11/17/2023JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$91.00 ➝ $81.00
11/14/2023Jefferies Financial GroupLower TargetBuy ➝ Buy$95.00 ➝ $85.00
11/9/2023The Goldman Sachs GroupLower TargetBuy ➝ Buy$98.00 ➝ $85.00
11/2/2023UBS GroupLower TargetBuy ➝ Buy$104.00 ➝ $94.00
11/1/2023Raymond James FinancialLower TargetStrong-Buy ➝ Strong-Buy$95.00 ➝ $90.00
10/31/2023MizuhoLower TargetBuy ➝ Buy$94.00 ➝ $77.00
10/31/2023Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$87.00 ➝ $72.00
10/20/2023Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$83.00 ➝ $71.00
9/14/2023Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$76.00 ➝ $94.00
8/14/2023The Goldman Sachs GroupBoost TargetBuy ➝ Buy$89.00 ➝ $98.00
8/2/2023Raymond James FinancialBoost TargetStrong-Buy ➝ Strong-Buy$85.00 ➝ $95.00
8/2/2023Credit Suisse GroupBoost TargetOutperform ➝ Outperform$92.00 ➝ $98.00
8/1/2023Royal Bank Of CanadaBoost TargetOutperformer ➝ Outperform$84.00 ➝ $87.00
8/1/2023UBS GroupBoost TargetBuy ➝ Buy$95.00 ➝ $104.00
8/1/2023StephensBoost TargetEqual Weight ➝ Equal Weight$87.00 ➝ $89.00
8/1/2023CitigroupBoost TargetBuy ➝ Buy$83.00 ➝ $90.00
7/11/2023MizuhoBoost Target$81.00 ➝ $94.00
6/20/2023Truist FinancialBoost Target$84.00 ➝ $92.00
5/16/2023MizuhoBoost Target$78.00 ➝ $81.00
4/26/2023Deutsche Bank AktiengesellschaftBoost Target$65.00 ➝ $81.00
4/26/2023StephensBoost Target$64.00 ➝ $77.00
4/26/2023Truist FinancialBoost Target$74.00 ➝ $84.00
4/26/2023Raymond James FinancialBoost Target$72.00 ➝ $85.00
4/26/2023Royal Bank Of CanadaBoost Target$73.00 ➝ $84.00
4/26/2023BarclaysBoost Target$70.00 ➝ $105.00
4/20/2023Cantor FitzgeraldInitiated CoverageOverweight$73.00
4/19/2023JPMorgan Chase & Co.Initiated CoverageOverweight$72.00
2/22/2023StephensBoost TargetEqual Weight$60.00 ➝ $64.00
2/17/2023Wells Fargo & CompanyBoost TargetOverweight$59.00 ➝ $68.00
2/17/2023MizuhoBoost TargetBuy$60.00 ➝ $78.00
2/14/2023UBS GroupBoost TargetBuy$47.00 ➝ $78.00
2/14/2023BarclaysBoost TargetOverweight$67.00 ➝ $70.00
2/10/2023Deutsche Bank AktiengesellschaftBoost TargetBuy$48.00 ➝ $65.00
2/10/2023Truist FinancialBoost TargetBuy$60.00 ➝ $66.00
2/10/2023Royal Bank Of CanadaBoost TargetOutperform$69.00 ➝ $73.00
2/10/2023MizuhoReiterated RatingBuy$60.00
2/10/2023StephensBoost TargetEqual Weight$57.00 ➝ $60.00
1/3/2023Wells Fargo & CompanyBoost TargetOverweight$48.00 ➝ $59.00
1/3/2023Truist FinancialBoost Target$55.00 ➝ $60.00
12/6/2022Loop CapitalBoost Target$40.00 ➝ $45.00
11/2/2022MizuhoLower TargetBuy$80.00 ➝ $60.00
11/1/2022The Goldman Sachs GroupLower TargetBuy$93.00 ➝ $80.00
10/27/2022Credit Suisse GroupLower Target$80.00
10/27/2022Raymond James FinancialLower TargetStrong-Buy$135.00 ➝ $80.00
10/25/2022CitigroupLower TargetBuy$99.00 ➝ $76.00
10/25/2022Leerink PartnersLower TargetOutperform$89.00 ➝ $55.00
10/24/2022StephensLower TargetEqual Weight$65.00 ➝ $45.00
10/24/2022Truist FinancialLower Target$80.00 ➝ $55.00
10/24/2022Deutsche Bank AktiengesellschaftLower TargetBuy$90.00 ➝ $48.00
10/24/2022Wells Fargo & CompanyLower TargetOverweight$82.00 ➝ $48.00
10/24/2022BarclaysLower TargetOverweight$104.00 ➝ $67.00
10/21/2022Bank of AmericaLower Target$79.00 ➝ $64.00
8/24/2022Leerink PartnersBoost TargetOutperform$88.00 ➝ $93.00
8/2/2022MizuhoBoost TargetBuy$63.00 ➝ $80.00
7/29/2022Wells Fargo & CompanyLower Target$90.00 ➝ $82.00
7/28/2022UBS GroupLower TargetBuy$113.00 ➝ $91.00
7/25/2022StephensBoost Target$73.00
7/25/2022Truist FinancialBoost TargetBuy$75.00 ➝ $80.00
7/25/2022Leerink PartnersBoost TargetOutperform$68.00 ➝ $88.00
7/25/2022CitigroupLower TargetBuy$110.00 ➝ $99.00
7/24/2022Bank of AmericaBoost Target$70.00 ➝ $75.00
7/19/2022Credit Suisse GroupSet Target$104.00
7/15/2022Leerink PartnersLower TargetOutperform$110.00 ➝ $68.00
7/12/2022The Goldman Sachs GroupLower TargetBuy$108.00 ➝ $93.00
7/11/2022Raymond James FinancialLower TargetStrong-Buy$120.00 ➝ $110.00
7/7/2022Deutsche Bank AktiengesellschaftLower TargetBuy$110.00 ➝ $90.00
7/1/2022MizuhoLower TargetBuy$103.00 ➝ $63.00
6/16/2022Loop CapitalInitiated CoverageBuy$80.00
4/25/2022Wells Fargo & CompanyLower TargetOverweight$100.00 ➝ $90.00
4/22/2022Leerink PartnersBoost TargetOutperform$100.00 ➝ $110.00
4/22/2022Royal Bank Of CanadaBoost TargetOutperform$89.00 ➝ $104.00
4/22/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$100.00 ➝ $110.00
4/22/2022CitigroupBoost TargetBuy$96.00 ➝ $110.00
4/22/2022BarclaysBoost TargetOverweight$99.00 ➝ $104.00
4/14/2022Leerink PartnersReiterated RatingBuy$100.00
4/7/2022Truist FinancialBoost Target$90.00 ➝ $100.00
3/28/2022Wells Fargo & CompanyInitiated CoverageOverweight$100.00
3/7/2022Jefferies Financial GroupBoost TargetBuy$120.00 ➝ $125.00
3/3/2022MizuhoBoost TargetBuy$90.00 ➝ $103.00
3/1/2022The Goldman Sachs GroupReiterated RatingBuy ➝ Buy
2/10/2022UBS GroupUpgradeNeutral ➝ Buy$83.00 ➝ $111.00
2/9/2022Credit Suisse GroupBoost TargetOutperform$109.00 ➝ $111.00
2/9/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$80.00 ➝ $100.00
2/9/2022Leerink PartnersUpgradeMarket Perform ➝ Outperform$88.00 ➝ $100.00
2/9/2022BarclaysBoost TargetOverweight$87.00 ➝ $99.00
2/9/2022Truist FinancialUpgradeHold ➝ Buy$90.00
1/20/2022Raymond James FinancialUpgradeOutperform ➝ Strong-Buy$105.00 ➝ $120.00
1/7/2022Leerink PartnersBoost TargetMarket Perform$78.00 ➝ $88.00
1/5/2022Truist FinancialBoost Target$78.00 ➝ $90.00
12/21/2021BarclaysBoost TargetOverweight$81.00 ➝ $87.00
11/10/2021MizuhoBoost TargetBuy$75.00 ➝ $90.00
11/9/2021StephensBoost TargetEqual Weight$77.00 ➝ $92.00
10/25/2021CitigroupBoost TargetBuy$88.00 ➝ $91.00
10/22/2021Leerink PartnersLower TargetMarket Perform$80.00 ➝ $78.00
10/22/2021Truist FinancialBoost TargetHold$72.00 ➝ $78.00
10/22/2021Credit Suisse GroupBoost TargetOutperform$88.00 ➝ $95.00
10/13/2021Truist FinancialLower TargetHold$78.00 ➝ $72.00
9/27/2021Leerink PartnersInitiated CoverageMarket Perform$80.00
9/23/2021UBS GroupInitiated CoverageNeutral$83.00
9/8/2021BarclaysBoost TargetOverweight$78.00 ➝ $79.00
8/12/2021BarclaysUpgradeEqual Weight ➝ Overweight$62.00 ➝ $77.00
8/9/2021MizuhoBoost TargetBuy$70.00 ➝ $75.00
7/23/2021Credit Suisse GroupBoost TargetOutperform$71.00 ➝ $88.00
7/23/2021CitigroupInitiated CoverageBuy$70.84
7/23/2021Royal Bank Of CanadaBoost TargetOutperform$78.00 ➝ $83.00
7/23/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$69.00 ➝ $80.00
7/9/2021Seaport Res PtnReiterated RatingBuy
6/18/2021Jefferies Financial GroupReiterated RatingBuy
5/5/2021MizuhoBoost TargetBuy$55.00 ➝ $70.00
5/3/2021The Goldman Sachs GroupInitiated CoverageBuy
4/23/2021BarclaysBoost Target$55.00 ➝ $62.00
4/22/2021Truist FinancialBoost Target$56.00 ➝ $60.00
4/22/2021CitigroupBoost Target$58.00 ➝ $65.00
4/22/2021Credit Suisse GroupBoost TargetOutperform$58.00 ➝ $71.00
4/22/2021Royal Bank Of CanadaBoost TargetOutperform$57.00 ➝ $66.00
4/9/2021MizuhoBoost TargetBuy$48.00 ➝ $55.00
2/11/2021CitigroupBoost Target$50.00 ➝ $58.00
2/11/2021Credit Suisse GroupBoost TargetOutperform$52.00 ➝ $58.00
1/21/2021UBS GroupBoost TargetPositive ➝ Buy$37.00 ➝ $60.00
1/14/2021Raymond James FinancialBoost TargetOutperform$55.00 ➝ $60.00
1/8/2021Jefferies Financial GroupUpgradeHold ➝ Buy$27.00 ➝ $60.00
1/5/2021Bank of AmericaUpgradeNeutral ➝ Buy$45.00 ➝ $50.00
12/18/2020MizuhoBoost TargetBuy$32.00 ➝ $48.00
12/15/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
12/11/2020Smith Barney CitigroupBoost Target$33.00 ➝ $50.00
12/11/2020Credit Suisse GroupBoost TargetOutperform$39.00 ➝ $48.00
12/11/2020BarclaysBoost TargetEqual Weight$28.00 ➝ $46.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.36 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 48 very positive mentions
  • 28 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 69 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 42 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
10/5/2025
  • 56 very positive mentions
  • 29 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 70 very positive mentions
  • 8 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 70 very positive mentions
  • 8 positive mentions
  • 3 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Tenet Healthcare logo
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Read More

Today's Range

Now: $212.02
Low: $209.06
High: $215.47

50 Day Range

MA: $203.22
Low: $186.60
High: $218.37

52 Week Range

Now: $212.02
Low: $109.82
High: $222.82

Volume

834,601 shs

Average Volume

976,396 shs

Market Capitalization

$18.63 billion

P/E Ratio

14.53

Dividend Yield

N/A

Beta

1.44

Frequently Asked Questions

What sell-side analysts currently cover shares of Tenet Healthcare?

The following Wall Street research analysts have issued stock ratings on Tenet Healthcare in the last year: Baird R W, Bank of America Corporation, Barclays PLC, Cantor Fitzgerald, Guggenheim, JPMorgan Chase & Co., KeyCorp, Mizuho, Morgan Stanley, Raymond James Financial, Inc., Robert W. Baird, Royal Bank Of Canada, Stephens, TD Cowen, The Goldman Sachs Group, Inc., Truist Financial Corporation, UBS Group AG, Wall Street Zen, Weiss Ratings, Wells Fargo & Company, Wolfe Research, and Zacks Research.
View the latest analyst ratings for THC.

What is the current price target for Tenet Healthcare?

0 Wall Street analysts have set twelve-month price targets for Tenet Healthcare in the last year. Their average twelve-month price target is $230.88, suggesting a possible upside of 8.9%. UBS Group AG has the highest price target set, predicting THC will reach $260.00 in the next twelve months. Robert W. Baird has the lowest price target set, forecasting a price of $167.00 for Tenet Healthcare in the next year.
View the latest price targets for THC.

What is the current consensus analyst rating for Tenet Healthcare?

Tenet Healthcare currently has 4 hold ratings, 16 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for THC.

What other companies compete with Tenet Healthcare?

Other companies that are similar to Tenet Healthcare include Alcon, Universal Health Services, Encompass Health, The Ensign Group and Brookdale Senior Living. Learn More about companies similar to Tenet Healthcare.

How do I contact Tenet Healthcare's investor relations team?

Tenet Healthcare's physical mailing address is 14201 Dallas Parkway, DALLAS TX, 75254. The company's listed phone number is (469) 893-2200 and its investor relations email address is [email protected]. The official website for Tenet Healthcare is www.tenethealth.com. Learn More about contacing Tenet Healthcare investor relations.